Citigroup Inc Arcutis Biotherapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 89,622 shares of ARQT stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,622

Previous 54,599 64.15%

Holding current value

$1.14 Million

Previous $507,000 64.3%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$8.32 - $11.0 $291,391 - $385,253	35,023 Added 64.15%	89,622 $833,000
Q2 2024 Aug 12, 2024	SELL	$7.24 - $12.53 $4.79 Million - $8.29 Million	-661,841 Reduced 92.38%	54,599 $507,000
Q1 2024 May 10, 2024	BUY	$3.25 - $11.77 $2.29 Million - $8.28 Million	703,727 Added 5535.49%	716,440 $7.1 Million
Q4 2023 Feb 09, 2024	SELL	$1.84 - $4.82 $301,960 - $791,005	-164,109 Reduced 92.81%	12,713 $41,000
Q3 2023 Nov 09, 2023	BUY	$5.31 - $10.98 $123,372 - $255,109	23,234 Added 15.13%	176,822 $938,000
Q2 2023 Aug 10, 2023	SELL	$7.51 - $15.0 $678,986 - $1.36 Million	-90,411 Reduced 37.05%	153,588 $1.46 Million
Q1 2023 May 11, 2023	BUY	$10.23 - $17.14 $1.13 Million - $1.9 Million	110,771 Added 83.14%	243,999 $2.68 Million
Q4 2022 Feb 09, 2023	SELL	$13.96 - $20.4 $380,731 - $556,369	-27,273 Reduced 16.99%	133,228 $1.97 Million
Q3 2022 Nov 10, 2022	BUY	$17.85 - $26.95 $2.05 Million - $3.09 Million	114,683 Added 250.3%	160,501 $3.07 Million
Q2 2022 Aug 10, 2022	BUY	$16.33 - $22.2 $558,730 - $759,573	34,215 Added 294.88%	45,818 $976,000
Q1 2022 May 12, 2022	SELL	$14.38 - $22.79 $1.56 Million - $2.48 Million	-108,637 Reduced 90.35%	11,603 $223,000
Q4 2021 Feb 10, 2022	BUY	$14.98 - $25.5 $1.43 Million - $2.43 Million	95,304 Added 382.19%	120,240 $2.49 Million
Q3 2021 Nov 10, 2021	BUY	$19.28 - $27.1 $480,766 - $675,765	24,936 New	24,936 $596,000

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $763M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account